ZENTALIS PHARMACEUTICALS INC
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About ZNTL
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. The Company is engaged in developing azenosertib (ZN-c3), a potentially first-in-class WEE1 inhibitor, for patients with ovarian cancer and other tumor types. The inhibition of WEE1, a DNA damage response kinase, drives cancer cells into mitosis without being able to repair damaged DNA, resulting in cell death and thereby preventing tumor growth and potentially causing tumor regression. WEE1 acts as a regulator of the G1-S and G2-M cell cycle checkpoints, through negative regulation of both CDK1 and CDK2, to prevent replication of cells with damaged DNA. In clinical trials, azenosertib has been well tolerated and has demonstrated anti-tumor activity as a single agent across multiple tumor types.
Find out what a historical investment in ZENTALIS PHARMACEUTICALS INC would be worth today using our ZNTL stock calculator.
$102.69M
-
0.00%
545.62K
$1.51
$1.41
$1.50
$13.24
$1.01
Ready to start your investing journey with Stake?
Open an accountZNTL FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ZNTL
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ZNTL
on Stake
Buy ZNTL from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of ZNTL from only US$10 with fractional shares
